NLM Logo

dexelvucitabine MeSH Supplementary Concept Data 2022


MeSH Supplementary
dexelvucitabine
Unique ID
C099405
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C099405
Entry Term(s)
2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine
2',3'-dideoxy-2',3'-didehydro-beta-D-5-fluorocytidine
2',3'-dideoxy-2',3'-didehydro-beta-L-5-fluorocytidine
2(1H)-Pyrimidinone, 4-amino-1-((2S,5R)-2,5-dihydro-5-(hydroxymethyl)-2-furanyl)-5-fluoro-
4-amino-5-fluoro-1-((2S,5R)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)pyrimidin-2(1H)-one
ACH-126-443
D-D4FC
DPC 817
DPC-817
DPC817
INCB-8721
L-D4FC
Reverset
beta-D-D4FC
beta-L-Fd4C
elvucitabine
Pharm Action
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Registry Number
KU8SPJ271W
Related Numbers
134379-77-4
M09BUF90C0
Heading Mapped to
Zalcitabine / *analogs & derivatives
Frequency
38
Note
inhibits human hepatitis B virus (HBV) and human immunodeficiency virus (HIV) in vitro
Source
J Med Chem 1996 Apr 26;39(9):1757-9
Date of Entry
1996/06/24
Revision Date
2020/11/24
dexelvucitabine Preferred
INCB-8721 Narrower
Reverset Narrower
DPC 817 Narrower
elvucitabine Narrower
2',3'-dideoxy-2',3'-didehydro-beta-D-5-fluorocytidine Narrower
page delivered in 0.005s